FI44905B - - Google Patents

Info

Publication number
FI44905B
FI44905B FI0985/66A FI98566A FI44905B FI 44905 B FI44905 B FI 44905B FI 0985/66 A FI0985/66 A FI 0985/66A FI 98566 A FI98566 A FI 98566A FI 44905 B FI44905 B FI 44905B
Authority
FI
Finland
Application number
FI0985/66A
Other languages
Finnish (fi)
Other versions
FI44905C (fi
Inventor
G Nathansohn
G Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of FI44905B publication Critical patent/FI44905B/fi
Publication of FI44905C publication Critical patent/FI44905C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/0035Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Machines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI660985A 1965-04-22 1966-04-16 Menetelmä 20-okso-pregnaani-, 20-okso-4-pregneeni- tai 20-okso-5(6)-pr egneeni-(17alfa, 16alfa-d)-oksatsoliinien valmistamiseksi FI44905C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB17027/65A GB1077392A (en) 1965-04-22 1965-04-22 New steroids
GB3586565 1965-08-20

Publications (2)

Publication Number Publication Date
FI44905B true FI44905B (es) 1971-11-01
FI44905C FI44905C (fi) 1972-02-10

Family

ID=26252388

Family Applications (2)

Application Number Title Priority Date Filing Date
FI660986A FI44906C (fi) 1965-04-22 1966-04-16 Analogiamenetelmä terapeuttisesti aktiivisten 11beta, 21-dihydroksi-3, 20-dionien tai 21-hydroksi-3,11,20-trioni-pregna-1,4-dieeni-(17alfa,16 alfa-d)-2'-metyylioksatsoliinien tai näiden 21-esterien valmistamiseks i
FI660985A FI44905C (fi) 1965-04-22 1966-04-16 Menetelmä 20-okso-pregnaani-, 20-okso-4-pregneeni- tai 20-okso-5(6)-pr egneeni-(17alfa, 16alfa-d)-oksatsoliinien valmistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI660986A FI44906C (fi) 1965-04-22 1966-04-16 Analogiamenetelmä terapeuttisesti aktiivisten 11beta, 21-dihydroksi-3, 20-dionien tai 21-hydroksi-3,11,20-trioni-pregna-1,4-dieeni-(17alfa,16 alfa-d)-2'-metyylioksatsoliinien tai näiden 21-esterien valmistamiseks i

Country Status (15)

Country Link
US (2) US3413286A (es)
AT (2) AT260440B (es)
BE (2) BE679821A (es)
BR (2) BR6678805D0 (es)
CH (2) CH471833A (es)
DE (3) DE1793662C3 (es)
DK (2) DK116870B (es)
ES (1) ES325755A1 (es)
FI (2) FI44906C (es)
FR (1) FR5645M (es)
GB (1) GB1077392A (es)
IL (2) IL25494A (es)
NL (3) NL6605174A (es)
NO (2) NO127346B (es)
SE (2) SE323675B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1119081A (en) * 1966-01-11 1968-07-10 Lepetit Spa New steroids
IT1141930B (it) * 1980-04-28 1986-10-08 Lepetit Spa Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche
IT1134455B (it) * 1980-11-26 1986-08-13 Lepetit Spa Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnanici
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
JP2009512677A (ja) * 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ホスホジエステラーゼタイプiv阻害剤の組成物
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CN101177443B (zh) * 2006-11-09 2011-08-03 天津药业研究院有限公司 新的甾体化合物及其应用
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
CA2680625C (en) 2007-03-14 2016-02-23 Ranbaxy Laboratories Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2874154A (en) * 1954-10-15 1959-02-17 Syntex Sa Process for the production of 20-keto-21-iodo steroids
US2923721A (en) * 1955-12-13 1960-02-02 Lab Francais Chimiotherapie Method of preparing 3-keto delta1, 4 steroids
DE1223376B (de) * 1963-12-14 1966-08-25 Hoechst Ag Verfahren zur Herstellung von 17alpha-Cyan-16alpha-hydroxy-steroiden der Pregnanreihe
US3349084A (en) * 1965-05-17 1967-10-24 Upjohn Co Steroidal [16, 17-d]-2'-isoxazolines of the pregnane series

Also Published As

Publication number Publication date
IL25493A (en) 1969-12-31
DE1568950A1 (de) 1970-11-26
US3413286A (en) 1968-11-26
FI44906B (es) 1971-11-01
SE323675B (es) 1970-05-11
ES325755A1 (es) 1967-02-16
CH453351A (fr) 1968-06-14
NO128152B (es) 1973-10-08
FR5645M (es) 1967-12-26
DE1793662C3 (de) 1973-11-08
DK117631B (da) 1970-05-19
AT265539B (de) 1968-10-10
US3436389A (en) 1969-04-01
DE1793662A1 (de) 1972-08-03
DK116870B (da) 1970-02-23
BE679821A (es) 1966-10-03
DE1568951A1 (de) 1970-06-18
BE679820A (es) 1966-10-03
CH471833A (fr) 1969-04-30
BR6678805D0 (pt) 1973-09-18
BR6679615D0 (pt) 1973-10-23
IL25494A (en) 1970-03-22
FI44905C (fi) 1972-02-10
NL6605375A (es) 1966-10-24
NL128816C (es)
GB1077392A (en) 1967-07-26
DE1793662B2 (de) 1973-04-19
SE323674B (es) 1970-05-11
FI44906C (fi) 1972-02-10
NO127346B (es) 1973-06-12
AT260440B (de) 1968-03-11
NL6605174A (es) 1966-10-24

Similar Documents

Publication Publication Date Title
FI44905B (es)
FI43730B (es)
JPS451095Y1 (es)
JPS4418376Y1 (es)
AU416352B2 (es)
JPS442844Y1 (es)
NL6604622A (es)
BE672210A (es)
BE660166A (es)
SE318603B (es)
NL6617774A (es)
BE661907A (es)
NL6608055A (es)
NL6605927A (es)
BE663720A (es)
BE666392A (es)
BE666658A (es)
BE666799A (es)
BE669260A (es)
BE670428A (es)
BE670553A (es)
BE671533A (es)
AU5791767A (es)
BE672117A (es)
BE675125A (es)